AURKB and head and neck squamous cell carcinoma: Studies show the association of AURKB overexpression with cisplatin resistance in gastric cancer cells, tamoxifen resistance in breast cancer and cetuximab resistance in head and neck squamous cell carcinoma.114, 115, 116